Curaleaf Holdings (CURLF) Capital Leases (2021 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Capital Leases of $144.4 million for Q4 2025, down 4.14% year-on-year from $150.7 million in Q4 2024, and down 4.14% on a QoQ basis from $150.7 million in Q4 2024.
Curaleaf Holdings (CURLF) Capital Leases (2021 - 2025) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Capital Leases for 5 consecutive years, with $144.4 million the latest figure, recorded in Q4 2025.
- Quarterly Capital Leases fell 4.14% year-over-year to $144.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $144.4 million (down 4.14% YoY) and the FY2025 annual result came in at $144.4 million, down 4.14% from the prior year.
- Capital Leases declined to $144.4 million in Q4 2025 per CURLF's latest filing, from $150.7 million in the prior quarter.
- Over the last five years, Capital Leases for CURLF reached as high as $167.4 million in Q4 2022 and fell as low as $109.7 million in Q4 2021.
- A 5-year average of $151.9 million and a median of $154.7 million in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2022 — Capital Leases surged 52.59% — and 2024, when it declined 5.97%.
- Year by year, Capital Leases stood at $109.7 million in 2021, then jumped by 52.59% to $167.4 million in 2022, then slipped by 4.45% to $160.0 million in 2023, then decreased by 5.8% to $150.7 million in 2024, then slipped by 4.14% to $144.4 million in 2025.
- According to Business Quant data, Capital Leases over the past three periods registered $144.4 million, $150.7 million, and $153.9 million for Q4 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 144.45 Mn |
| Dec 31, 2024 | 150.68 Mn |
| Sep 30, 2024 | 153.91 Mn |
| Jun 30, 2024 | 154.69 Mn |
| Dec 31, 2023 | 159.96 Mn |
| Sep 30, 2023 | 162.06 Mn |
| Jun 30, 2023 | 164.51 Mn |
| Dec 31, 2022 | 167.41 Mn |
| Dec 31, 2021 | 109.71 Mn |